Clinical Trial Update: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ML-007C-MA for schizophrenia in inpatient adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ML-007C-MA

Snippet

Sponsor: MapLight Therapeutics | Conditions: Schizophrenia | Phase 2 | Status: RECRUITING